Clinical trial to study the effect of Budesonide taken through inhalation in mild COVID cases
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/10/028581
- Lead Sponsor
- Dr Tushar Patel
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patient with RT-PCR OR Rapid Antigen confirmed diagnosis of Covid-19.
asymptomatic Patent with mild symptoms of less than 5 days duration.
3.Spo2 >94% at room air.
4.No Radiological evidence of Pneumonia.
5 Patient aged >18years to 99Years.
Exclusion Criteria
1. Patient requiring hospitaisation.
2. Patient unable to take the drug as drirected and comply with study procedure.
3.Vulnerable population(Pregnant women,Lactating women,Prisoners,Unable to consent).
4 Patients on Systemic/Inhalational Steroids.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HospitalizationTimepoint: 10 - 14 days depending on the onset of symptoms
- Secondary Outcome Measures
Name Time Method noTimepoint: no